Humanigen, Inc. - Common Stock (NQ:HGEN)

HGEN SHAREHOLDER ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN

Topics Lawsuit

September 21, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - HGEN

Topics Lawsuit

September 16, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN

Topics Lawsuit

September 15, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Humanigen (NASDAQ:HGEN) reported its Q2 earnings results on Friday, August 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Topics Lawsuit

Recap: Humanigen Q2 Earnings ↗

August 13, 2022

Via Benzinga

Humanigen, Inc. (NASDAQ:HGEN) Shareholder Notice: Lawsuit Alleges Misleading Statements ↗

September 15, 2022

San Diego, CA -- (SBWIRE) -- 09/15/2022 -- An investor, who purchased shares of Humanigen, Inc. (NASDAQ:HGEN), filed a lawsuit over alleged violations of Federal Securities Laws by Humanigen, Inc. in...

Via SBWire

Humanigen and SAHMRI Announce Expansion of the PREACH-M Study of Lenzilumab in CMML

September 12, 2022

Short Hills, New Jersey and Adelaide, South Australia--(Newsfile Corp. - September 12, 2022) - Humanigen, Inc. (Nasdaq: HGEN), Humanigen Australia...

Via Newsfile

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN

September 11, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Humanigen, Inc. Shareholder News: Robbins LLP is Investigating Humanigen, Inc. (HGEN) on Behalf of Investors

Topics Lawsuit

September 07, 2022

From Robbins LLP

Humanigen to Participate in H.C. Wainwright and Cantor Investor Conferences in September 2022

September 07, 2022

Short Hills, New Jersey--(Newsfile Corp. - September 7, 2022) - Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused...

Via Newsfile

HGEN EQUITY ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - HGEN

September 05, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Humanigen, Inc. (HGEN) Investors of Class Action and Encourages Investors to Actively Participate

Topics Lawsuit

September 02, 2022

From Bronstein, Gewirtz & Grossman, LLC

HGEN Shareholder Update: Robbins LLP Reminds Investors of Class Action Filed Against Humanigen, Inc. (HGEN)

August 30, 2022

From Robbins LLP

HUMANIGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humanigen, Inc. and Encourages Investors to Contact the Firm

August 29, 2022

From Bragar Eagel & Squire, P.C.

Humanigen, Inc. Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Humanigen, Inc. (HGEN)

August 29, 2022

From Robbins LLP

Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday ↗

August 30, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 29, 2022

Via Benzinga

August 29, 2022

Gainers Advanced Human Imaging Limited (NASDAQ: AHI) shares jumped 53% to $1.04. Advanced Human Imaging announced Sunday it signed a Master Services Agreement with Estonia-based Activate Health OÜ.

Via Benzinga

EQUITY ALERT: Rosen Law Firm Encourages Humanigen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – HGEN

August 29, 2022

From Rosen Law Firm

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Humanigen, Inc. with Losses of $100,000 to Contact the Firm

August 29, 2022

From The Schall Law Firm

Apple (AAPL) stock is in the news as the company may finally be about ready to enter the VR space after years of headset rumors.

AAPL Stock Alert: Is Apple Making Moves in the Virtual Reality Space? ↗

August 29, 2022

Pinduoduo (PDD) stock is getting a boost on Monday after the Chinese agriculture tech company released results for Q2 2022.

Why Is Pinduoduo (PDD) Stock Up 18% Today? ↗

August 29, 2022

Fans of AMC Entertainment (AMC) stock will want to keep an eye on the company come Sept. 3 as it prepares for a special theater event.

Dear AMC Stock Fans, Mark Your Calendars for Sept. 3 ↗

August 29, 2022

Humanigen (HGEN) stock is heading lower on Monday as investors react to a minimum price delisting notice from the Nasdaq Exchange.

Why Is Humanigen (HGEN) Stock Down 16% Today? ↗

August 29, 2022

We're breaking down the biggest pre-market stock movers and the news that has them rising and falling for Monday morning!

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 29, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

August 29, 2022

Gainers NewAge, Inc. (NASDAQ: NBEV) shares rose 19.7% to $0.2432 in pre-market trading. NewAge recently received Nasdaq notice on late filing of its form 10-Q.

Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket ↗

August 29, 2022

Via Benzinga

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Humanigen, Inc. with Losses of $100,000 to Contact the Firm

August 27, 2022

From The Schall Law Firm

NASDAQ:HGEN Shareholder Notice: Investigation over Possible Securities Laws Violations by Humanigen, Inc. ↗

August 17, 2022

San Diego, CA -- (SBWIRE) -- 08/17/2022 -- Humanigen, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Humanigen Reports Second Quarter 2022 Financial Results

August 12, 2022

From Humanigen, Inc.